Brief: Onxeo Announces Approval Of Its REVocan Study

Valerio Therapeutics SA

29/05/2020 06:54

May 29 (Reuters) - ONXEO SA  C4X.PA :
    * ONXEO ANNOUNCES APPROVAL OF REVOCAN STUDY BY REGULATORY
AUTHORITIES
    * FIRST TREATMENTS COULD BEGIN IN NEXT FEW WEEKS, WITH
OBJECTIVE
OF FIRST RESULTS LATE 2020/EARLY 2021
    * FIRST PATIENTS COULD BE RECRUITED AS EARLY AS Q3 OF 2020,
WITH
AIM OF OBTAINING PRELIMINARY RESULTS AT END OF 2020 OR EARLY IN
2021

Source text for Eikon:  ID:nBw3vgbsta 
Further company coverage:  C4X.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))